Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
01) and further lowered to 68% of control at 10 µM
Pre-treatment with 10 μM inhibits migration to a significantly greater extent than the lower dose in both assays
CBDivE_000728
and nuclear translocation of NF-ᴋB in RAW 264
is a galectin-3 inhibitor potentially for the treatment of idiopathic pulmonary fibrosis (IPF)
Aprepitant erin HCl 01) and further lowered toAprepitant is a small molecule, high affinity substance P antagonist (SPA) with antiemetic activity. Crossing the blood brain barrier, aprepitant binds selectively to the human substance P neurokinin 1 receptor in the central nervous system (CNS), thereby inhibiting receptor binding of endogenous substance P and substance P induced emesis. This agent has little or no affinity for serotonin type 3 (5 HT3), dopamine, and corticosteroid receptors.
US$ 130.00
US$ 12.00
US$ 2150000.00
US$ 14.00